tirzepatide pancreatitis warning People using GLP-1 weight-loss injections such as Wegovy have been advised to stay alert to a rare but serious risk of acute pancreatitis, a severe inflammation of the pancreas. The Medicines and Do Weight Loss Injections Cause

Cardiovascular and Metabolic Risk Factors That Matter Patients with a history of hypertension, coronary artery disease, arrhythmia, or family history of sudden cardiac death should not combine these agents without exhaustive cardiac evaluation

"We will continue to assess pricing as our goal is always to improve access by providing patients and healthcare professionals with additional treatment options but ensuring that we maintain the same high quality standards," she said

Additional information Supplementary Information accompanies the paper on the Translational Psychiatry website Rights and permissions This work is licensed under a Creative Commons Attribution 4.0 International License

Her response

Nanoparticles offer several advantages over traditional therapies, including improved drug delivery, targeted therapeutic interventions, and crossing biological barriers like the BBB

Weight Loss Goal Guarantee